Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

NYSE:DNA   11:22:24 AM EDT
5.30
+0.26 (+5.16%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.37B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$55.25 Million
Adjusted EPS-$0.04
See more estimates
10-Day MA$6.16
50-Day MA$10.01
200-Day MAN/A
See more pivots

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A Stock, NYSE:DNA

27 Drydock Avenue, 8th floor, Boston, Massachusetts 02210
United States of America
Phone: +1.877.422.5362
Number of Employees:

Description

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.